A recent study revealed that the intraperitoneal injection of the ACLY inhibitor SB-204990 in mice attenuated tumorigenicity [134].Berberine inhibits ACLY-induced lipid metabolism disorders and delays the malignant process of pancreatic cancer [135]. The gene discussed is ACLY; the disease is familial pancreatic carcinoma.